-+ 0.00%
-+ 0.00%
-+ 0.00%

SpyGlass Pharma Q1 EPS $(0.69) Misses $(0.42) Estimate

Benzinga·05/14/2026 21:04:21
Listen to the news
SpyGlass Pharma (NASDAQ:SGP) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.42) by 64.29 percent. This is a 82.58 percent increase over losses of $(3.96) per share from the same period last year.